298 related articles for article (PubMed ID: 19687359)
1. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more.
Raj SR; Black BK; Biaggioni I; Paranjape SY; Ramirez M; Dupont WD; Robertson D
Circulation; 2009 Sep; 120(9):725-34. PubMed ID: 19687359
[TBL] [Abstract][Full Text] [Related]
2. Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trial.
Green EA; Black BK; Biaggioni I; Paranjape SY; Bagai K; Shibao C; Okoye MC; Dupont WD; Robertson D; Raj SR
Cardiovasc Ther; 2014 Jun; 32(3):105-12. PubMed ID: 24495468
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome.
Coffin ST; Black BK; Biaggioni I; Paranjape SY; Orozco C; Black PW; Dupont WD; Robertson D; Raj SR
Heart Rhythm; 2012 Sep; 9(9):1484-90. PubMed ID: 22561596
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome.
Raj SR; Black BK; Biaggioni I; Harris PA; Robertson D
Circulation; 2005 May; 111(21):2734-40. PubMed ID: 15911704
[TBL] [Abstract][Full Text] [Related]
5. Splanchnic Venous Compression Enhances the Effects of ß-Blockade in the Treatment of Postural Tachycardia Syndrome.
Smith EC; Diedrich A; Raj SR; Gamboa A; Shibao CA; Black BK; Peltier A; Paranjape SY; Biaggioni I; Okamoto LE
J Am Heart Assoc; 2020 Jul; 9(14):e016196. PubMed ID: 32673517
[TBL] [Abstract][Full Text] [Related]
6. Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome.
Green EA; Raj V; Shibao CA; Biaggioni I; Black BK; Dupont WD; Robertson D; Raj SR
J Am Heart Assoc; 2013 Sep; 2(5):e000395. PubMed ID: 24002370
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic profiles and tolerability of modafinil in the treatment of postural tachycardia syndrome: a randomized, placebo-controlled trial.
Kpaeyeh J; Mar PL; Raj V; Black BK; Arnold AC; Biaggioni I; Shibao CA; Paranjape SY; Dupont WD; Robertson D; Raj SR
J Clin Psychopharmacol; 2014 Dec; 34(6):738-41. PubMed ID: 25222185
[TBL] [Abstract][Full Text] [Related]
8. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome.
Fu Q; Vangundy TB; Shibata S; Auchus RJ; Williams GH; Levine BD
Hypertension; 2011 Aug; 58(2):167-75. PubMed ID: 21690484
[TBL] [Abstract][Full Text] [Related]
9. Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study.
Arnold AC; Okamoto LE; Diedrich A; Paranjape SY; Raj SR; Biaggioni I; Gamboa A
Neurology; 2013 May; 80(21):1927-33. PubMed ID: 23616163
[TBL] [Abstract][Full Text] [Related]
10. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome.
Ross AJ; Ocon AJ; Medow MS; Stewart JM
Clin Sci (Lond); 2014 Feb; 126(4):289-96. PubMed ID: 23978222
[TBL] [Abstract][Full Text] [Related]
11. Postural tachycardia syndrome and inappropriate sinus tachycardia: role of autonomic modulation and sinus node automaticity.
Nwazue VC; Paranjape SY; Black BK; Biaggioni I; Diedrich A; Dupont WD; Robertson D; Raj SR
J Am Heart Assoc; 2014 Apr; 3(2):e000700. PubMed ID: 24721800
[TBL] [Abstract][Full Text] [Related]
12. Acute hemodynamic effects of a selective serotonin reuptake inhibitor in postural tachycardia syndrome: a randomized, crossover trial.
Mar PL; Raj V; Black BK; Biaggioni I; Shibao CA; Paranjape SY; Dupont WD; Robertson D; Raj SR
J Psychopharmacol; 2014 Feb; 28(2):155-61. PubMed ID: 24227635
[TBL] [Abstract][Full Text] [Related]
13. Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
Nwazue VC; Arnold AC; Raj V; Black BK; Biaggioni I; Paranjape SY; Orozco C; Dupont WD; Robertson D; Raj SR
Clin Exp Pharmacol Physiol; 2014 May; 41(5):325-30. PubMed ID: 24606242
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.
Moon J; Kim DY; Lee WJ; Lee HS; Lim JA; Kim TJ; Jun JS; Park B; Byun JI; Sunwoo JS; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee SK; Chu K
Neurotherapeutics; 2018 Jul; 15(3):785-795. PubMed ID: 29500811
[TBL] [Abstract][Full Text] [Related]
15. Short-term efficacy of ORS formulation and propranolol regimen in children with POTS.
Yozgat Y; Temur HO; Coban S; Oner T; Karaarslan U; Yozgat CY; Karadeniz C; Ergor SN; Erenberk U
Arch Pediatr; 2020 Aug; 27(6):328-332. PubMed ID: 32651146
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
Reynolds GK; Lewis DP; Richardson AM; Lidbury BA
J Intern Med; 2014 Apr; 275(4):409-17. PubMed ID: 24206536
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin in the treatment of postural orthostatic tachycardia syndrome.
Kanjwal K; Saeed B; Karabin B; Kanjwal Y; Sheikh M; Grubb BP
Am J Ther; 2012 Mar; 19(2):92-5. PubMed ID: 20838326
[TBL] [Abstract][Full Text] [Related]
18. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience.
Kanjwal K; Karabin B; Sheikh M; Elmer L; Kanjwal Y; Saeed B; Grubb BP
Pacing Clin Electrophysiol; 2011 Jun; 34(6):750-5. PubMed ID: 21410722
[TBL] [Abstract][Full Text] [Related]
19. Malmö POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome.
Spahic JM; Hamrefors V; Johansson M; Ricci F; Melander O; Sutton R; Fedorowski A
J Intern Med; 2023 Jan; 293(1):91-99. PubMed ID: 36111700
[TBL] [Abstract][Full Text] [Related]
20. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone.
Freitas J; Santos R; Azevedo E; Costa O; Carvalho M; de Freitas AF
Clin Auton Res; 2000 Oct; 10(5):293-9. PubMed ID: 11198485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
